ArticleInternational urogynecology journal2026
3D MRI Biomarkers for Predicting Pelvic Organ Prolapse Risk and Severity.
Article in International urogynecology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo identify 3D MRI-derived biomarkers of the cardinal ligament (CL) and uterosacral ligament (USL) for pelvic organ prolapse (POP) risk and stress urinary incontinence (SUI), and to evaluate their correlations with prolapse severity.
methodsFemale patients undergoing pelvic MRI at *** Hospital (2021-2023) were grouped into POP and control cohorts. MRI data underwent 3D reconstruction (Mimics software) and modeling (Geomagic/Solidworks) to precisely measure ligament parameters.
resultsWomen with POP had longer postmenopausal intervals, and higher parity but similar age, Body Mass Index (BMI), Lean Body Mass (LBM) and Body Surface Area (BSA). CL volume, surface area, mass, and maximal thickness were significantly reduced in POP (all
conclusion3D MRI quantification of CL metrics (volume, area, mass) offers noninvasive biomarkers for POP and SUI risk prediction, unlike USL morphology. These markers improve pelvic floor failure understanding and enable early POP risk identification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.